Market Place
Sourcing Support
MDC Seeks Clarity On Nafithromycin Exemption From DPCO
30 Sep 2025 //
PHARMABIZ
Lancet Regional Health Releases Key Phase 3 Study On Miqnaf
26 Sep 2025 //
INDPHARMAPOST
CDSCO approves Wockhardt’s new generation oral antibiotic Miqnaf
04 Jan 2025 //
EXPRESSPHARMA
Indian Pharma Develops Drug To Combat Antibiotic Resistance
05 Dec 2024 //
BUSINESS STD
Soft Launch Of Nafithromycin To Combat AMR AnnounceBy Dr. Jitendra
21 Nov 2024 //
EXPRESSPHARMA
Indian Regulator Recommends Wockhardt`s Miqnaf for CABP
14 Oct 2024 //
INDPHARMAPOST
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.